Accelerating the Speed of Discovery
Andy Plump, President of Research & Development at Takeda, joins David Berry on Averin Insights to discuss how technology is changing drug discovery and development.
Conversations from Averin Capital
Averin Insights
The future of human health.
Averin Capital brings you inside conversations with the people shaping the future of human health. We explore the science opening new doors, the technologies changing what’s possible, and the work of building companies that bring those advances to patients.
Get new episodes by email ↓
The conversations
Explore all Averin insights →
Betting on Breakthrough Biology
Christian Schubert, Vice President and Global Head of AbbVie Ventures, joins David Berry on Averin Insights to discuss early-stage biotech investing, working with founders, and where AI can make a meaningful difference in drug discovery.
Before Disease Decides
Thierry Bernard, CEO of QIAGEN, joins David Berry on Averin Insights to explore how diagnostics could help healthcare move from reacting to disease toward earlier detection and more personalized care.
Stay in the conversation.
Get new Averin Insights episodes and our latest writing on technology and human health in your inbox.